EpiPens still costly — despite generic alternatives, other reforms

The out-of-pocket cost of anti-allergy injectors such as EpiPens jumped nearly 124% from 2007 to 2014, which helped to spur calls for reform in 2016. Today, the cost of epinephrine autoinjectors remain high, despite the recent introduction of generic versions and other reforms, advocates say.